Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol (August 9, 2006). doi:10.1152/ajpcell.00243.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/C33    most recent
00243.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chicco, A. J
Right arrow Articles by Sparagna, G. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chicco, A. J
Right arrow Articles by Sparagna, G. C
Submitted on May 4, 2006
Accepted on August 1, 2006

Role of cardiolipin alterations in mitochondrial dysfunction and disease

Adam J Chicco1 and Genevieve C Sparagna1*

1 Integrative Physiology, University of Colorado at Boulder, Boulder, Colorado, United States

* To whom correspondence should be addressed. E-mail: sparagna{at}spot.colorado.edu.

Cardiolipin (CL) is a structurally unique dimeric phospholipid localized in the inner mitochondrial membrane where it is required for optimal mitochondrial function. In addition to its role in maintaining membrane potential and architecture, CL is known to provide essential structural and functional support to several proteins involved in mitochondrial bioenergetics. A loss of CL content, alterations in its acyl chain composition, and/or CL peroxidation have been associated with mitochondrial dysfunction in multiple tissues in a variety of pathological conditions including ischemia, hypothyroidism, aging, and heart failure. Recently, aberrations in CL metabolism have been implicated as a primary causative factor in the cardioskeletal myopathy known as Barth syndrome, underscoring an important role of CL in human health and disease. The purpose of this review is to provide an overview of evidence that has linked changes in the CL profile to mitochondrial dysfunction in various pathological conditions. In addition, a brief overview of CL function and biosynthesis, and a discussion of methods used to examine CL in biological tissues are provided.




This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
M. A. Kiebish, X. Han, H. Cheng, J. H. Chuang, and T. N. Seyfried
Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer
J. Lipid Res., December 1, 2008; 49(12): 2545 - 2556.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
N. Khalifat, N. Puff, S. Bonneau, J.-B. Fournier, and M. I. Angelova
Membrane Deformation under Local pH Gradient: Mimicking Mitochondrial Cristae Dynamics
Biophys. J., November 15, 2008; 95(10): 4924 - 4933.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Nguyen, M. Ogbi, and J. A. Johnson
Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester: IMPLICATIONS FOR F1F0 ATPase REGULATION
J. Biol. Chem., October 31, 2008; 283(44): 29831 - 29840.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
S. M. Claypool, Y. Oktay, P. Boontheung, J. A. Loo, and C. M. Koehler
Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane
J. Cell Biol., September 9, 2008; 182(5): 937 - 950.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. J. Chicco, G. C. Sparagna, S. A. McCune, C. A. Johnson, R. C. Murphy, D. A. Bolden, M. L. Rees, R. T. Gardner, and R. L. Moore
Linoleate-Rich High-Fat Diet Decreases Mortality in Hypertensive Heart Failure Rats Compared With Lard and Low-Fat Diets
Hypertension, September 1, 2008; 52(3): 549 - 555.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Devi, V. Raghavendran, B. M. Prabhu, N. G. Avadhani, and H. K. Anandatheerthavarada
Mitochondrial Import and Accumulation of {alpha}-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
J. Biol. Chem., April 4, 2008; 283(14): 9089 - 9100.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. J. Chicco, S. A. McCune, C. A. Emter, G. C. Sparagna, M. L. Rees, D. A. Bolden, K. D. Marshall, R. C. Murphy, and R. L. Moore
Low-Intensity Exercise Training Delays Heart Failure and Improves Survival in Female Hypertensive Heart Failure Rats
Hypertension, April 1, 2008; 51(4): 1096 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Kulik, H. van Lenthe, F. S. Stet, R. H. Houtkooper, H. Kemp, J. E. Stone, C. G. Steward, R. J. Wanders, and F. M. Vaz
Bloodspot Assay Using HPLC-Tandem Mass Spectrometry for Detection of Barth Syndrome
Clin. Chem., February 1, 2008; 54(2): 371 - 378.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Jahangir, S. Sagar, and A. Terzic
Aging and cardioprotection
J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. C. Sparagna, A. J. Chicco, R. C. Murphy, M. R. Bristow, C. A. Johnson, M. L. Rees, M. L. Maxey, S. A. McCune, and R. L. Moore
Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure
J. Lipid Res., July 1, 2007; 48(7): 1559 - 1570.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.